Product Code: ETC9947674 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Lipid POCT Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Lipid POCT Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Lipid POCT Market - Industry Life Cycle |
3.4 United Kingdom (UK) Lipid POCT Market - Porter's Five Forces |
3.5 United Kingdom (UK) Lipid POCT Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) Lipid POCT Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United Kingdom (UK) Lipid POCT Market Revenues & Volume Share, By Mode, 2021 & 2031F |
3.8 United Kingdom (UK) Lipid POCT Market Revenues & Volume Share, By Brand, 2021 & 2031F |
3.9 United Kingdom (UK) Lipid POCT Market Revenues & Volume Share, By Platform, 2021 & 2031F |
3.10 United Kingdom (UK) Lipid POCT Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.11 United Kingdom (UK) Lipid POCT Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Lipid POCT Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in the UK leading to a higher demand for lipid testing |
4.2.2 Technological advancements in lipid POCT devices making testing more efficient and accurate |
4.2.3 Growing focus on preventive healthcare and wellness programs driving the adoption of lipid POCT testing |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for lipid POCT devices limiting market entry |
4.3.2 High cost associated with lipid POCT devices and tests hindering widespread adoption |
4.3.3 Lack of awareness among healthcare professionals and patients about the benefits of lipid POCT testing |
5 United Kingdom (UK) Lipid POCT Market Trends |
6 United Kingdom (UK) Lipid POCT Market, By Types |
6.1 United Kingdom (UK) Lipid POCT Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.4 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.5 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Kits, 2021- 2031F |
6.2 United Kingdom (UK) Lipid POCT Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Hyperlipidemia, 2021- 2031F |
6.2.3 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Hypertriglyceridemia, 2021- 2031F |
6.2.4 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Hyperlipoproteinemia, 2021- 2031F |
6.2.5 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Familial hypercholesterolemia, 2021- 2031F |
6.2.6 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Tangier Disease, 2021- 2031F |
6.2.7 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Lipid POCT Market, By Mode |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Prescription-Based Testing, 2021- 2031F |
6.3.3 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By OTC-Based Testing, 2021- 2031F |
6.4 United Kingdom (UK) Lipid POCT Market, By Brand |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Roche Reflotron, 2021- 2031F |
6.4.3 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Roche Cobas B 101, 2021- 2031F |
6.4.4 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Alere Cholestech LDX, 2021- 2031F |
6.4.5 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Alere Afinion, 2021- 2031F |
6.4.6 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Samsung Labgeo, 2021- 2031F |
6.4.7 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By PTS Cardiochek, 2021- 2031F |
6.5 United Kingdom (UK) Lipid POCT Market, By Platform |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Lateral Flow Assays (Immunochromatography Tests), 2021- 2031F |
6.5.3 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Molecular Diagnostics, 2021- 2031F |
6.5.4 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Immunoassays, 2021- 2031F |
6.5.5 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Dipsticks, 2021- 2031F |
6.5.6 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Microfluidics, 2021- 2031F |
6.6 United Kingdom (UK) Lipid POCT Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Professional Diagnostic Centers, 2021- 2031F |
6.6.4 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Home Care, 2021- 2031F |
6.6.5 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Research Laboratories, 2021- 2031F |
6.6.6 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Other End Users, 2021- 2031F |
6.7 United Kingdom (UK) Lipid POCT Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.7.3 United Kingdom (UK) Lipid POCT Market Revenues & Volume, By Retail Sales, 2021- 2031F |
7 United Kingdom (UK) Lipid POCT Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Lipid POCT Market Export to Major Countries |
7.2 United Kingdom (UK) Lipid POCT Market Imports from Major Countries |
8 United Kingdom (UK) Lipid POCT Market Key Performance Indicators |
8.1 Average turnaround time for lipid POCT testing |
8.2 Rate of adoption of lipid POCT devices in primary care settings |
8.3 Number of partnerships and collaborations between lipid POCT device manufacturers and healthcare providers |
8.4 Percentage of healthcare professionals trained in using lipid POCT devices |
8.5 Patient satisfaction scores related to lipid POCT testing experience |
9 United Kingdom (UK) Lipid POCT Market - Opportunity Assessment |
9.1 United Kingdom (UK) Lipid POCT Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) Lipid POCT Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United Kingdom (UK) Lipid POCT Market Opportunity Assessment, By Mode, 2021 & 2031F |
9.4 United Kingdom (UK) Lipid POCT Market Opportunity Assessment, By Brand, 2021 & 2031F |
9.5 United Kingdom (UK) Lipid POCT Market Opportunity Assessment, By Platform, 2021 & 2031F |
9.6 United Kingdom (UK) Lipid POCT Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 United Kingdom (UK) Lipid POCT Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Lipid POCT Market - Competitive Landscape |
10.1 United Kingdom (UK) Lipid POCT Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Lipid POCT Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |